City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Eileen Smith, MD  
Search results:  1  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-1 Trials Jump to page:

COH Protocol Number: 08179 ClinicalTrials.gov Number: NCT01476839

Principal Investigator: Eileen Smith, MD
Sponsor: NCI Approved External Peer Review

Title:  Phase I/II Study of Yttrium-90 Labeled Anti-CD25 (a-Tac) Monoclonal Antibody Plus BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Primary Refractory or Relapsed Hodgkin Lymphoma, the "a-Tac BEAM Regimen"

 
Results per page: 25 50 100 All 1-1 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.